$IPWR
Ideal Power Inc. Stock $ipwr

$ipwr Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000114420414067379 Filed on November 13, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q3
Revenue	$500.0K	$438.0K	$608.2K
YoY Change	100.0%	-27.98%	68.94%
Cost Of Revenue	$610.0K	$533.5K	$619.9K
YoY Change	1.67%	-13.93%	87.83%
Gross Profit	-$110.0K	-$95.51K	-$11.69K
YoY Change	-68.57%	717.34%	-138.95%
Gross Profit Margin	-22.0%	-21.8%	-1.92%
Selling, General & Admin	$1.130M	$1.074M	$571.1K
YoY Change	36.14%	87.99%	63.17%
% of Gross Profit
Research & Development	$770.0K	$689.4K	$261.1K
YoY Change	97.44%	164.08%	-6.77%
% of Gross Profit
Depreciation & Amortization	$30.00K	$20.00K	$10.00K
YoY Change	200.0%	100.0%	0.0%
% of Gross Profit
Operating Expenses	$1.900M	$1.763M	$832.1K
YoY Change	54.47%	111.86%	32.09%
Operating Profit	-$2.010M	-$1.858M	-$843.8K
YoY Change	27.22%	120.24%	40.64%
Interest Expense	$10.00K	$10.00K	-$1.320M
YoY Change	-100.5%	-100.76%	180.85%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.000M	-$1.850M	-$2.160M
YoY Change	-43.98%	-14.35%	101.87%
Income Tax		$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.000M	-$1.852M	-$2.165M
YoY Change	-43.98%	-14.46%	102.31%
Net Earnings / Revenue	-400.0%	-422.77%	-355.95%
Basic Earnings Per Share
Diluted Earnings Per Share	-$2.857M	-$2.643M	-$14.40M
COMMON SHARES
Basic Shares Outstanding	7.048M shares	7.015M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.910M	$9.730M	$280.0K
YoY Change	-44.06%	3375.0%
Cash & Equivalents	$7.912M	$9.730M	$278.8K
Short-Term Investments
Other Short-Term Assets	$100.6K	$110.0K	$470.0K
YoY Change	315.2%	-76.6%
Inventory	$251.3K	$343.9K	$380.0K
Prepaid Expenses
Receivables	$446.5K	$399.8K	$970.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.873M	$10.58M	$2.100M
YoY Change	-41.39%	403.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$374.4K	$331.2K	$40.00K
YoY Change	336.75%	728.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$17.92K	$35.84K
YoY Change
Total Long-Term Assets	$1.405M	$1.279M	$650.0K
YoY Change	102.3%	96.82%
TOTAL ASSETS
Total Short-Term Assets	$8.873M	$10.58M	$2.100M
Total Long-Term Assets	$1.405M	$1.279M	$650.0K
Total Assets	$10.28M	$11.86M	$2.750M
YoY Change	-35.09%	331.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$441.6K	$429.4K	$1.440M
YoY Change	-18.09%	-70.18%
Accrued Expenses	$773.1K	$741.8K	$410.0K
YoY Change	67.63%	80.93%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$4.680M
YoY Change
Total Short-Term Liabilities	$1.215M	$1.171M	$6.560M
YoY Change	21.43%	-82.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$1.190M
YoY Change		-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$1.190M
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.215M	$1.171M	$6.560M
Total Long-Term Liabilities	$0.00	$0.00	$1.190M
Total Liabilities	$1.210M	$1.170M	$7.750M
YoY Change	20.96%	-84.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$23.65M	-$21.65M
YoY Change	41.19%
Common Stock	$7.048K	$7.022K
YoY Change	1.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$2.657K	$2.657K
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	$9.064M	$10.69M	-$5.000M
YoY Change
Total Liabilities & Shareholders Equity	$10.28M	$11.86M	$2.750M
YoY Change	-35.09%	331.27%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q3
OPERATING ACTIVITIES
Net Income	-$2.000M	-$1.852M	-$2.165M
YoY Change	-43.98%	-14.46%	102.31%
Depreciation, Depletion And Amortization	$30.00K	$20.00K	$10.00K
YoY Change	200.0%	100.0%	0.0%
Cash From Operating Activities	-$1.650M	-$1.320M	-$660.0K
YoY Change	48.65%	100.0%	-9.59%
INVESTING ACTIVITIES
Capital Expenditures	-$170.0K	-$100.0K	-$40.00K
YoY Change	240.0%	150.0%	33.33%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	-$170.0K	-$100.0K	-$40.00K
YoY Change	240.0%	150.0%	33.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	610.0K
YoY Change	-100.0%	-100.0%	-23.75%
NET CHANGE
Cash From Operating Activities	-1.650M	-1.320M	-660.0K
Cash From Investing Activities	-170.0K	-100.0K	-40.00K
Cash From Financing Activities	0.000	0.000	610.0K
Net Change In Cash	-1.820M	-1.420M	-90.00K
YoY Change	-113.13%	1477.78%	-325.0%
FREE CASH FLOW
Cash From Operating Activities	-$1.650M	-$1.320M	-$660.0K
Capital Expenditures	-$170.0K	-$100.0K	-$40.00K
Free Cash Flow	-$1.480M	-$1.220M	-$620.0K
YoY Change	39.62%	96.77%	-11.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Trading Symbol TradingSymbol	IPWR
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7048235	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Incorporation State Country Name EntityIncorporationStateCountryName	Delaware
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2013-07-15
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2013Q3	us-gaap	Revenue From Grants RevenueFromGrants	370672	USD
CY2014Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	741803	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	461193	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1171231	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14137097	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	115634	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	331218	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	85718	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9730268	USD
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	399769	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	252406	USD
CY2014Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	106699	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	231495	USD
CY2013Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	102652	USD
CY2014Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	201364	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	10580647	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	15140655	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	912249	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	608913	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35840	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
CY2014Q3	us-gaap	Assets Assets	11859954	USD
CY2013Q4	us-gaap	Assets Assets	15835286	USD
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	429428	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	539145	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	417005	USD
CY2014Q3	us-gaap	Inventory Net InventoryNet	343911	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	519657	USD
CY2014Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	231431	USD
CY2013Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	46733	USD
CY2014Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	41500	USD
CY2013Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	46850	USD
CY2014Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	157800	USD
CY2013Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	107769	USD
CY2014Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	430731	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	201352	USD
CY2014Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	99513	USD
CY2014Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	142547	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	1737237	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	825610	USD
CY2013Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	95734	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	840565	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.04
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7015156	shares
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1480262	shares
	us-gaap	Gross Profit GrossProfit	-101044	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	475353	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2225996	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	31431220	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1000338	USD
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	7022	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	6932	USD
CY2014Q3	ipwr	Common Stock Value Stock Compensation Earned But Not Issued CommonStockValueStockCompensationEarnedButNotIssued	0	USD
CY2013Q4	ipwr	Common Stock Value Stock Compensation Earned But Not Issued CommonStockValueStockCompensationEarnedButNotIssued	151665	USD
CY2014Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	32336720	USD
	us-gaap	Revenues Revenues	1289650	USD
	us-gaap	Revenues Revenues	1638586	USD
CY2014Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	393665	USD
CY2013Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	236505	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1078843	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	539342	USD
CY2014Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	165588	USD
CY2014Q3	us-gaap	Treasury Stock Value TreasuryStockValue	2657	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2657	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21652362	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16752212	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	10688723	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	14834948	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11859954	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15835286	USD
CY2014Q3	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	38581	USD
CY2014Q3	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	156394	USD
CY2014Q3	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	159941	USD
CY2014Q3	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	163489	USD
CY2014Q3	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear	68736	USD
CY2014Q3	us-gaap	Other Commitment OtherCommitment	587141	USD
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	289000	USD
CY2013Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	212495	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	841600	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	396465	USD
CY2014Q3	us-gaap	Royalty Revenue RoyaltyRevenue	0	USD
CY2013Q3	us-gaap	Royalty Revenue RoyaltyRevenue	25000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	0	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	75000	USD
CY2014Q3	us-gaap	Revenue From Grants RevenueFromGrants	149029	USD
	us-gaap	Revenue From Grants RevenueFromGrants	448050	USD
	us-gaap	Revenue From Grants RevenueFromGrants	1167121	USD
CY2014Q3	us-gaap	Revenues Revenues	438029	USD
CY2013Q3	us-gaap	Revenues Revenues	608167	USD
CY2013Q3	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	383347	USD
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	497833	USD
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1200288	USD
CY2014Q3	us-gaap	Cost Of Revenue CostOfRevenue	559253	USD
CY2013Q3	us-gaap	Cost Of Revenue CostOfRevenue	619852	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1576676	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1739630	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	-121224	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	-11685	USD
	us-gaap	Gross Profit GrossProfit	-287026	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	663678	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	832140	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	762741	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1254193	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	261053	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1568711	USD
CY2014Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	310818	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	308080	USD
	us-gaap	Operating Expenses OperatingExpenses	4635272	USD
	us-gaap	Operating Expenses OperatingExpenses	2387883	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1858461	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-843825	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4922298	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2488927	USD
CY2014Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6617	USD
CY2013Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1320943	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	22148	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3487802	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-1851844	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-2164768	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4900150	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5976729	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.46
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.70
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	7008634	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1480262	shares
CY2014Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	470564	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	249160	USD
CY2014Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	130449	USD
CY2013Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	113078	USD
CY2014Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	140790	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	98955	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3348284	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1273512	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-SIZE: 10pt">Concentration of Credit Risk</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable and accounts payable. The Company maintains its cash with a major financial institution located in the United States. Balances are insured by the Federal Deposit Insurance Corporation up to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">250,000</font>. The Company maintains balances in excess of federally insured limits. The Company has not experienced losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company encounters a certain amount of risk as a result of a concentration of revenue from a few significant customers. Credit is extended to customers based on an evaluation of their financial condition. The Company generally does not require collateral or other security to support accounts receivable. The Company performs ongoing credit evaluations of its customers and records an allowance for potential bad debts based on available information.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company had revenue from the U.S. Department of Energy’s Advanced Research Projects Agency-Energy (“ARPA-E”) that accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 35</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 62</font>% of net revenue for the nine months ended September 30, 2014 and 2013, respectively, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 34</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 61</font>% of net revenue for the three months ended September 30, 2014 and 2013, respectively.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company had revenue from three customers which accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 15</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 11</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% of net revenue for the nine months ended September 30, 2014. The Company had revenue from three different customers which accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>%, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 16</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 11</font>% of net revenue for the three months ended September 30, 2014 and revenue from another customer which accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 10</font>% of net revenue for the three months ended September 30, 2013.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company had an accounts receivable balance from ARPA-E that accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 40</font>% and 84% of total accounts receivable at September 30, 2014 and December 31, 2013, respectively. The Company had accounts receivable balances with two customers which accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 24</font>% and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 18</font>%, respectively, of total accounts receivable at September 30, 2014.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	43248	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21155	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	5199	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	597055	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	150340	USD
	ipwr	Stock Compensation Earned But Not Issued StockCompensationEarnedButNotIssued	50004	USD
	ipwr	Stock Compensation Earned But Not Issued StockCompensationEarnedButNotIssued	124393	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	101879	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	0	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	60000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	147363	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	483603	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-175746	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	168076	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-88956	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	440257	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-109717	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	754753	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	280610	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	233142	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	25000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3819732	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2133106	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	278318	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32036	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	313766	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	139631	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-592084	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-171667	USD
	ipwr	Proceeds From Exercise Of Options And Warrants ProceedsFromExerciseOfOptionsAndWarrants	4987	USD
	ipwr	Proceeds From Exercise Of Options And Warrants ProceedsFromExerciseOfOptionsAndWarrants	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4987	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	611256	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-4406829	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1693517	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1972301	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	278784	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	86949	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	27592	USD
CY2014Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	50176	USD
CY2013Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	9961	USD
	ipwr	Issuance Of Note Payable In Connection With Services IssuanceOfNotePayableInConnectionWithServices	0	USD
	ipwr	Issuance Of Note Payable In Connection With Services IssuanceOfNotePayableInConnectionWithServices	213293	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	611256	USD
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7021721	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6931968	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7021721	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6931968	shares
CY2014Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	40000	shares
CY2014Q3	us-gaap	Grants Receivable Current GrantsReceivableCurrent	159679	USD
CY2013Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	211063	USD
	ipwr	Research And Development Expense Including Grants ResearchAndDevelopmentExpenseIncludingGrants	2066544	USD
	ipwr	Research And Development Expense Including Grants ResearchAndDevelopmentExpenseIncludingGrants	2025898	USD
	ipwr	Research And Development Expense Grants ResearchAndDevelopmentExpenseGrants	497833	USD
	ipwr	Research And Development Expense Grants ResearchAndDevelopmentExpenseGrants	1200288	USD
CY2014Q3	ipwr	Research And Development Expense Including Grants ResearchAndDevelopmentExpenseIncludingGrants	829266	USD
CY2013Q3	ipwr	Research And Development Expense Including Grants ResearchAndDevelopmentExpenseIncludingGrants	644400	USD
CY2014Q3	ipwr	Research And Development Expense Grants ResearchAndDevelopmentExpenseGrants	165588	USD
CY2013Q3	ipwr	Research And Development Expense Grants ResearchAndDevelopmentExpenseGrants	383347	USD
CY2014Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	USD
	us-gaap	Property Plant And Equipment Depreciation Methods PropertyPlantAndEquipmentDepreciationMethods	straight-line method
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-2.381 reverse stock split
CY2014Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2014Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	USD
CY2013Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	USD
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2013	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
	ipwr	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice	10374

Files In Submission

Name	View Source	Status
0001144204-14-067379-index-headers.html	Edgar Link	pending
0001144204-14-067379-index.html	Edgar Link	pending
0001144204-14-067379.txt	Edgar Link	pending
0001144204-14-067379-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ipwr-20140930.xml	Edgar Link	completed
ipwr-20140930.xsd	Edgar Link	pending
ipwr-20140930_cal.xml	Edgar Link	unprocessable
ipwr-20140930_def.xml	Edgar Link	unprocessable
ipwr-20140930_lab.xml	Edgar Link	unprocessable
ipwr-20140930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tpg17.jpg	Edgar Link	pending
tpg18.jpg	Edgar Link	pending
tpg20.jpg	Edgar Link	pending
v393736_10q.htm	Edgar Link	pending
v393736_ex31-1.htm	Edgar Link	pending
v393736_ex31-2.htm	Edgar Link	pending
v393736_ex32-1.htm	Edgar Link	pending
v393736_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IPWR
Ideal Power Inc. Stock $ipwr

2014 Q4 Form 10-Q Financial Statement

#000114420414067379 Filed on November 13, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IPWR Ideal Power Inc. Stock $ipwr

2014 Q4 Form 10-Q Financial Statement

#000114420414067379 Filed on November 13, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IPWR
Ideal Power Inc. Stock $ipwr